Levothyroxine therapy reduces endocan and total cholesterol concentrations in patients with subclinical hypothyroidism
A mild form of SCH is associated with higher concentrations of endocan, ADMA, LDL and non-HDL. The potential benefits of levothyroxine therapy were shown through the significant decrease of endocan and CHOL concentrations in SCH patients, thus contributing the atherosclerosis prevention.
Authors
- Anita Somborac Bačura (ORCID: https://orcid.org/0000-0002-8573-4294)
- Ivana Zec
- Marina Čeprnja
- Tanja Bobetić-Vranić
- Tihana Serdar Hiršl
- Tomislav Jukić (ORCID: https://orcid.org/0000-0001-5631-164X)
- Koraljka Đurić (ORCID: https://orcid.org/0000-0002-1735-1865)
- Marijana Kraljević Šmalcelj
Institutions
- Synlab Czech (Czechia) (CZ)
- University Hospital Centre Zagreb (HR)
- University of Zagreb (HR)
- Children's Hospital Srebrnjak (HR)
- Children's Hospital Zagreb (HR)
Publication Details
- Journal
- Biochemia Medica
- Published
- 2024-12-16
- DOI
- https://doi.org/10.11613/bm.2025.010703
- Primary Topic
- Inflammation biomarkers and pathways
- Type
- article
- Field-Weighted Citation Impact
- 0.00